N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen

C78H101ClF5N23O4S3 — CID 158428978

IUPACN-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen
SMILESCc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(NC(=O)[C@H]4CCCN4C(C)C)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(N4CCOCC4)C3)nc(Sc3ccc(NC(=O)C4(C(F)(F)F)CC4)cc3)n2)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)c4ccccc4Cl)cc3)nc(N3CCC3)c2F)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H35FN8OS.C26H29F3N8O2S.C24H21ClFN7OS.8H2/c1-17(2)37-12-4-5-22(37)26(38)30-20-8-10-21(11-9-20)39-27-32-23(31-24-13-18(3)34-35-24)14-25(33-27)36-15-28(29,16-36)19-6-7-19;1-16-12-21(35-34-16)31-20-13-22(37-14-18(15-37)36-8-10-39-11-9-36)33-24(32-20)40-19-4-2-17(3-5-19)30-23(38)25(6-7-25)26(27,28)29;1-14-13-19(32-31-14)28-21-20(26)22(33-11-4-12-33)30-24(29-21)35-16-9-7-15(8-10-16)27-23(34)17-5-2-3-6-18(17)25;;;;;;;;/h8-11,13-14,17,19,22H,4-7,12,15-16H2,1-3H3,(H,30,38)(H2,31,32,33,34,35);2-5,12-13,18H,6-11,14-15H2,1H3,(H,30,38)(H2,31,32,33,34,35);2-3,5-10,13H,4,11-12H2,1H3,(H,27,34)(H2,28,29,30,31,32);8*1H/t22-;;;;;;;;;;/m1........../s1
InChIKeyHBKMRWCXXYDOBT-BZVKDZAESA-N
MW1651.47 g/mol
LogP16.98
Rot. Bonds24

About N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen

N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen (PubChem CID 158428978) has the molecular formula C78H101ClF5N23O4S3 and a molecular weight of 1651.47 g/mol. Its IUPAC name is N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen.

Molecular Properties

Compound NameN-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen
PubChem CID158428978
Molecular FormulaC78H101ClF5N23O4S3
Molecular Weight1651.47 g/mol
Exact Mass1649.72
IUPAC NameN-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen
SMILESCc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(NC(=O)[C@H]4CCCN4C(C)C)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(N4CCOCC4)C3)nc(Sc3ccc(NC(=O)C4(C(F)(F)F)CC4)cc3)n2)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)c4ccccc4Cl)cc3)nc(N3CCC3)c2F)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H35FN8OS.C26H29F3N8O2S.C24H21ClFN7OS.8H2/c1-17(2)37-12-4-5-22(37)26(38)30-20-8-10-21(11-9-20)39-27-32-23(31-24-13-18(3)34-35-24)14-25(33-27)36-15-28(29,16-36)19-6-7-19;1-16-12-21(35-34-16)31-20-13-22(37-14-18(15-37)36-8-10-39-11-9-36)33-24(32-20)40-19-4-2-17(3-5-19)30-23(38)25(6-7-25)26(27,28)29;1-14-13-19(32-31-14)28-21-20(26)22(33-11-4-12-33)30-24(29-21)35-16-9-7-15(8-10-16)27-23(34)17-5-2-3-6-18(17)25;;;;;;;;/h8-11,13-14,17,19,22H,4-7,12,15-16H2,1-3H3,(H,30,38)(H2,31,32,33,34,35);2-5,12-13,18H,6-11,14-15H2,1H3,(H,30,38)(H2,31,32,33,34,35);2-3,5-10,13H,4,11-12H2,1H3,(H,27,34)(H2,28,29,30,31,32);8*1H/t22-;;;;;;;;;;/m1........../s1
InChIKeyHBKMRWCXXYDOBT-BZVKDZAESA-N
XLogP16.98
TPSA312.20 Ų
H-Bond Donors9
H-Bond Acceptors24
Rotatable Bonds24
Heavy Atoms114
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001651.47
LogP ≤ 516.98
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1024

Analyze N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen?
The IUPAC name of N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen (CID 158428978) is N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen.
What is the SMILES notation for N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen?
The canonical SMILES for N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen is Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(NC(=O)[C@H]4CCCN4C(C)C)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(N4CCOCC4)C3)nc(Sc3ccc(NC(=O)C4(C(F)(F)F)CC4)cc3)n2)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)c4ccccc4Cl)cc3)nc(N3CCC3)c2F)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen?
The InChIKey is HBKMRWCXXYDOBT-BZVKDZAESA-N. The full InChI is InChI=1S/C28H35FN8OS.C26H29F3N8O2S.C24H21ClFN7OS.8H2/c1-17(2)37-12-4-5-22(37)26(38)30-20-8-10-21(11-9-20)39-27-32-23(31-24-13-18(3)34-35-24)14-25(33-27)36-15-28(29,16-36)19-6-7-19;1-16-12-21(35-34-16)31-20-13-22(37-14-18(15-37)36-8-10-39-11-9-36)33-24(32-20)40-19-4-2-17(3-5-19)30-23(38)25(6-7-25)26(27,28)29;1-14-13-19(32-31-14)28-21-20(26)22(33-11-4-12-33)30-24(29-21)35-16-9-7-15(8-10-16)27-23(34)17-5-2-3-6-18(17)25;;;;;;;;/h8-11,13-14,17,19,22H,4-7,12,15-16H2,1-3H3,(H,30,38)(H2,31,32,33,34,35);2-5,12-13,18H,6-11,14-15H2,1H3,(H,30,38)(H2,31,32,33,34,35);2-3,5-10,13H,4,11-12H2,1H3,(H,27,34)(H2,28,29,30,31,32);8*1H/t22-;;;;;;;;;;/m1........../s1.
What are the key properties of N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen?
N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen has a molecular weight of 1651.47 g/mol, XLogP of 16.98, 24 rotatable bonds, 9 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[4-(azetidin-1-yl)-5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-chlorobenzamide;(2R)-N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-propan-2-ylpyrrolidine-2-carboxamide;N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(3-morpholin-4-ylazetidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]-1-(trifluoromethyl)cyclopropane-1-carboxamide;molecular hydrogen is sourced from PubChem (CID 158428978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).